| Literature DB >> 25099666 |
Mathieu Molimard1, Corine Bernaud2, Philippe Lechat3, Theodora Bejan-Angoulvant4, Cherif Benattia5, Amel Benkritly6, David Braunstein7, Sandrine Cabut8, Nadine David9, Annie Fourrier-Réglat10, Benoit Gallet11, Marta Gersberg12, Sylvia Goni13, Pascale Jolliet14, Véronique Lamarque-Garnier15, Claire Le Jeunne16, Irina Leurs17, François Liard18, Muriel Malbezin19, Joelle Micallef7, Marina Nguon20.
Abstract
Recent drug crises have highlighted the complexity, benefits and risks of medication communication. The difficulty of this communication is due to the diversity of the sources of information and the target audience, the credibility of spokespersons, the difficulty to communicate on scientific uncertainties and the precautionary principle, which is influenced by variable perceptions and tolerances of the risk. Globally, there is a lack of training in risk management with a tendency of modern society to refuse even the slightest risk. Communication on medications is subject to regulatory or legal requirements, often uses tools and messages that are not adapted to the target audience and is often based on a poor knowledge of communication techniques. In order to improve this situation, the available information must be coordinated by reinforcing the unique medication information website and by coordinating communication between authorities by means of a single spokesperson. A particular effort must be made in the field of training in the proper use and risk of medications for both the general population and patients but also for healthcare professionals, by setting up a unified academic on-line teaching platform for continuing medical education on medications and their proper use.Entities:
Mesh:
Year: 2014 PMID: 25099666 DOI: 10.2515/therapie/2014045
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070